UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up its sleeve – it’s just become the first and only FDA-approved treatment for lupus ...

Registrazione video del dibattito dal titolo "Presentazione del libro di Carlo Romeo "Il muro e il silenzio" (Arcadia Edizioni, 2025)", registrato a Roma venerdì 4 aprile 2025 alle ore 18:09.

Background Abnormalities of type I interferon signaling and production can initiate lupus development. Disturbances of nucleic acid-sensing molecules triggered autoreactivity in lupus mouse models.

Early signs of lupus in females, such as fatigue, joint pain, and rashes, are commonly mistaken for symptoms of other conditions. Lupus is an autoimmune disease that's far more common in females than ...

Lupus eritematoso sistemico disseminato e malattia mista del tessuto connettivo (aumentato rischio di meningite asettica, vedere paragrafo 4.8). Uso concomitante di altri farmaci vasocostrittori usati ...

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been approved as add-on therapies for SLE in China. The aim of this study is to ...

Lupus eritematoso disseminato; Uso concomitante di altri vasocostrittori utilizzati come decongestionanti nasali, somministrati per via orale o nasale (vedere paragrafo 4.5); Uso concomitante di ...